REQUEST A DEMO
Total
USD $0.00
Search more companies

Procaps S.A. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Procaps S.A. Profile Updated: September 03, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Procaps S.A. вas born in 1977 and has since become a pioneer in the development of soft gelatin capsules for Colombia and the Andean Community. The company is a marketer and producer of pharmaceutical specialties, offering contract manufacturing services to laboratories such as Wyeth, Merck, Bagon and others. The company has operations in Ecuador, Venezuela, Dominican Republic, Peru, Guatemala, Bolivia and the United States.

Headquarters
Cl 80 Cr 78 B 201
Barranquilla; Atlantico;

Contact Details: Purchase the Procaps S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Procaps S.A. report to view the information.
Outstanding Shares:
Purchase the Procaps S.A. report to view the information.
Registered Capital:
Purchase the Procaps S.A. report to view the information.
Incorporation Date:
July 22, 1976
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Subsidiaries
Pharmayect S.A.
82.1%
Funtrition Sas
Company Performance
Financial values in the chart are available after Procaps S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
3.91%
Total operating revenue
25.08%
Operating profit (EBIT)
45.66%
EBITDA
34.78%
Net Profit (Loss) for the Period
-4.28%
Total assets
-10.31%
Total equity
-11.71%
Operating Profit Margin (ROS)
4.91%
Net Profit Margin
-0.27%
Return on Equity (ROE)
0.96%
Debt to Equity Ratio
4.77%
Quick Ratio
-0.03%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?